𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mild gestational hyperglycaemia as a risk factor for metabolic syndrome in pregnancy and adverse perinatal outcomes

✍ Scribed by Carlos Antonio Negrato; Lois Jovanovic; Marcos Antonio Tambascia; Iracema de Mattos Paranhos Calderon; Bruno Geloneze; Adriano Dias; Marilza Vieira Cunha Rudge


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
112 KB
Volume
24
Category
Article
ISSN
1520-7552

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Objective

The aims of this study were to evaluate the prevalence of metabolic syndrome (MS) in a cohort of pregnant women with a wide range of glucose tolerance, pre‐pregnancy risk factors for MS during pregnancy and the effects of MS in the occurrence of adverse perinatal outcomes.

Research Design and Methods

One hundred and thirty six women with positive screening for gestational diabetes (GDM) were classified by two diagnostic methods: glycaemic profile and 100 g oral glucose tolerance test (OGTT) as normoglycaemic, mild gestational hyperglycaemic, GDM, and overt GDM. Markers of insulin resistance were measured between 24–28 and 36th week of gestation, and 6 weeks after delivery.

Results

The prevalence of MS was 0; 20.0; 23.5 and 36.4% in normoglycaemic, mild hyperglycaemic, GDM and overt GDM groups, respectively. Previous history of GDM with or without insulin use, body mass index (BMI) ≥ 25, hypertension, family history of diabetes in first‐degree relatives, non‐Caucasian ethnicity, history of prematurity and polyhydramnios were statistically significant pre‐pregnancy predictors for MS in the index pregnancy, that by its turn increased the occurrence of adverse perinatal outcomes (p = 0.01).

Conclusions

The prevalence of MS increases with the worsening of glucose tolerance and is an independent predictor of adverse perinatal outcomes; impaired glycaemic profile identifies pregnancies with important metabolic abnormalities that are linked to the occurrence of adverse perinatal outcomes even in the presence of a normal OGTT, in patients that are not currently classified as having GDM. Copyright © 2008 John Wiley & Sons, Ltd.